Cargando…

Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors

OBJECTIVE: Previous studies have reported an association between endometrial cancer and the risk of metabolic syndrome; however, the pattern of endometrial cancer-associated dyslipidemia is not well understood. The standard therapy for endometrial cancer is total abdominal hysterectomy and bilateral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirasawa, Akira, Makita, Kazuya, Akahane, Tomoko, Yokota, Megumi, Yamagami, Wataru, Banno, Kouji, Susumu, Nobuyuki, Aoki, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814898/ https://www.ncbi.nlm.nih.gov/pubmed/23999769 http://dx.doi.org/10.1093/jjco/hyt125

Ejemplares similares

Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese women
por: Yokota, Megumi, et al.
Publicado: (2015)

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018)

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
por: Inoue, Osamu, et al.
Publicado: (2016)

Endometrial Cancer as a Familial Tumor: Pathology and Molecular Carcinogenesis (Review)
por: Banno, Kouji, et al.
Publicado: (2009)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013)

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012)

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer
por: Masuda, Kenta, et al.
Publicado: (2017)

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer
por: Masuda, Kenta, et al.
Publicado: (2017)

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)

Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013)

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
por: Masuda, Kenta, et al.
Publicado: (2011)

New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013)

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
por: Hirasawa, Akira, et al.
Publicado: (2017)

Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer
por: Makabe, Takeshi, et al.
Publicado: (2019)

MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
por: Yanokura, Megumi, et al.
Publicado: (2020)

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes
por: Yoshihama, Tomoko, et al.
Publicado: (2018)

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome
por: Masuda, Kenta, et al.
Publicado: (2011)

Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
por: BANNO, KOUJI, et al.
Publicado: (2012)

Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
por: MASUDA, KENTA, et al.
Publicado: (2012)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation
por: MASUDA, KENTA, et al.
Publicado: (2012)

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer
por: Yanokura, Megumi, et al.
Publicado: (2017)

Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience
por: Nogami, Yuya, et al.
Publicado: (2020)

Mutations of RAS genes in endometrial polyps
por: Takeda, Takashi, et al.
Publicado: (2019)

Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)
por: BANNO, KOUJI, et al.
Publicado: (2013)

Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report
por: Takeda, Takashi, et al.
Publicado: (2018)

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
por: Nanki, Yoshiko, et al.
Publicado: (2020)

Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

MicroRNAS in endometrial cancer: recent advances and potential clinical applications
por: Yanokura, Megumi, et al.
Publicado: (2015)

Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
por: Hirano, Takuro, et al.
Publicado: (2022)

New use of microsatellite instability analysis in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2017)

LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2019)

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015)

Current status of uterine regenerative medicine for absolute uterine factor infertility
por: Matoba, Yusuke, et al.
Publicado: (2019)

ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016)

Current status and future directions of ovarian cancer prognostic models
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

Considerations in performing hysterectomy secondary to uterus transplantation
por: Kisu, Iori, et al.
Publicado: (2022)

Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
por: Takeda, Takashi, et al.
Publicado: (2018)

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene
por: Masuda, Kenta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dlgrkdjgijnvkkcguepv2uib35